These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19937911)

  • 1. Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface.
    Balyasnikova IV; Franco-Gou R; Mathis JM; Lesniak MS
    J Tissue Eng Regen Med; 2010 Jun; 4(4):247-58. PubMed ID: 19937911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma.
    Balyasnikova IV; Ferguson SD; Sengupta S; Han Y; Lesniak MS
    PLoS One; 2010 Mar; 5(3):e9750. PubMed ID: 20305783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of humanized single-chain fragment variable immunotherapeutic against EGFR variant III using baculovirus expression system and in vitro validation.
    Xavier S; Gopi Mohan C; Nair S; Menon KN; Vijayachandran LS
    Int J Biol Macromol; 2019 Mar; 124():17-24. PubMed ID: 30471391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an EGFRvIII specific recombinant antibody.
    Gupta P; Han SY; Holgado-Madruga M; Mitra SS; Li G; Nitta RT; Wong AJ
    BMC Biotechnol; 2010 Oct; 10():72. PubMed ID: 20925961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers.
    Rahbarnia L; Farajnia S; Babaei H; Majidi J; Dariushnejad H; Hosseini MK
    Immunol Lett; 2016 Dec; 180():31-38. PubMed ID: 27984065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy.
    Yan F; Li X; Li N; Zhang R; Wang Q; Ru Y; Hao X; Ni J; Wang H; Wu G
    Cancer Lett; 2017 Aug; 402():32-42. PubMed ID: 28529067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
    Kuan CT; Wikstrand CJ; Archer G; Beers R; Pastan I; Zalutsky MR; Bigner DD
    Int J Cancer; 2000 Dec; 88(6):962-9. PubMed ID: 11093822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of a functional single-chain variable fragment (scFv) protein recognizing MCF7 breast cancer cells in E. coli cytoplasm.
    Mahgoub IO
    Biochem Genet; 2012 Aug; 50(7-8):625-41. PubMed ID: 22552770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
    Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
    Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.
    Kuramitsu S; Ohno M; Ohka F; Shiina S; Yamamichi A; Kato A; Tanahashi K; Motomura K; Kondo G; Kurimoto M; Senga T; Wakabayashi T; Natsume A
    Cancer Gene Ther; 2015 Oct; 22(10):487-95. PubMed ID: 26450624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.
    Chen Y; Huang K; Li X; Lin X; Zhu Z; Wu Y
    Cancer Immunol Immunother; 2010 Jun; 59(6):933-42. PubMed ID: 20224978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of scFv antibody library screening technology based on flow cytometry].
    Xu L; Ren G; Yin J; Tian H; Li D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):65-8. PubMed ID: 23294720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme.
    Rahmani R; Kiani J; Tong WY; Soleimani M; Voelcker NH; Arefian E
    J Drug Target; 2023 Mar; 31(3):310-319. PubMed ID: 36440540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Analysis of a Novel Human EGFRvIII:CD3 Bispecific Antibody in Plasma and Whole Blood Using a High-Resolution Targeted Mass Spectrometry Approach.
    Schaller TH; Foster MW; Thompson JW; Spasojevic I; Normantaite D; Moseley MA; Sanchez-Perez L; Sampson JH
    J Proteome Res; 2019 Aug; 18(8):3032-3041. PubMed ID: 31267741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization.
    Zhu X; Wang D; Li S; Xiao Q; Tao K; Hu J; Cao W; Feng W
    Int J Mol Med; 2012 May; 29(5):939-45. PubMed ID: 22322313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and binding analyses of a humanised scFv against a cryptic epitope on tumour-associated fibronectin.
    Johdi NA; Harman R; Sanjuan I; Kousparou C; Courtenay-Luck N; Deonarain MP
    Protein Expr Purif; 2013 Mar; 88(1):157-63. PubMed ID: 23291225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor].
    Chen Y; Guo J; Yin Y; Jiang M; Zhu H; Zhang G; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):960-3. PubMed ID: 25200159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Intercellular Communication between Prostate Cancer Cells by A Specific Anti-STEAP-1 Single Chain Antibody.
    Esmaeili SA; Nejatollahi F; Sahebkar A
    Anticancer Agents Med Chem; 2018; 18(12):1674-1679. PubMed ID: 29219059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris.
    Wan L; Zhu S; Zhu J; Yang H; Li S; Li Y; Cheng J; Lu X
    Appl Microbiol Biotechnol; 2013 May; 97(9):3855-63. PubMed ID: 23250227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology.
    Rahbarnia L; Farajnia S; Babaei H; Majidi J; Akbari B; Ahdi Khosroshahi S
    Adv Pharm Bull; 2016 Dec; 6(4):563-571. PubMed ID: 28101463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.